NDC Code(s) : 0179-0238-70, 0179-0239-70
Packager : KAISER FOUNDATION HOSPITALS

Category : HUMAN PRESCRIPTION DRUG LABEL

DEA Schedule : none

Marketing Status : New Drug Application

INGREDIENTS AND APPEARANCE

Liothyronine SodiumLiothyronine Sodium TABLET
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0179-0238(NDC:51862-320)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Liothyronine Sodium(UNII: GCA9VV7D2N)
(liothyronine - UNII:06LU7C9H1V) 		liothyronine5 ug
Inactive Ingredients
Ingredient Name Strength
calcium sulfate, unspecified form(UNII: WAT0DDB505)
microcrystalline cellulose(UNII: OP1R32D61U)
hypromellose, unspecified(UNII: 3NXW29V3WO)
talc(UNII: 7SEV7J4R1U)
silicon dioxide(UNII: ETJ7Z6XBU4)
Product Characteristics
Color WHITE Score no score
Shape ROUND Size 7 mm
Flavor Imprint Code 5;220
Contains
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0179-0238-7030 in 1 BOX, UNIT-DOSE Type 0: Not a Combination Product04/04/2018
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090097 04/04/2018
Liothyronine SodiumLiothyronine Sodium TABLET
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0179-0239(NDC:51862-321)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Liothyronine Sodium(UNII: GCA9VV7D2N)
(liothyronine - UNII:06LU7C9H1V) 		liothyronine25 ug
Inactive Ingredients
Ingredient Name Strength
calcium sulfate, unspecified form(UNII: WAT0DDB505)
microcrystalline cellulose(UNII: OP1R32D61U)
hypromellose, unspecified(UNII: 3NXW29V3WO)
talc(UNII: 7SEV7J4R1U)
silicon dioxide(UNII: ETJ7Z6XBU4)
Product Characteristics
Color WHITE Score 2 pieces
Shape ROUND Size 7 mm
Flavor Imprint Code 25;222
Contains
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0179-0239-7030 in 1 BOX, UNIT-DOSE Type 0: Not a Combination Product04/04/2018
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090097 04/04/2018

PRINCIPAL DISPLAY PANEL

NDC 0179-0238-70

Liothyronine
Sodium Tablets, USP

5 mcg

Rx Only
Box of 30 Unit Dose Tablets

KASIER FOUNDATION HOSPITALS

PRINCIPAL DISPLAY PANEL - 5 mcg Tablet Box of 30 Unit Dose

PRINCIPAL DISPLAY PANEL

NDC 0179-0239-70

Liothyronine
Sodium Tablets, USP

25 mcg

Rx Only
Box of 30 Unit Dose Tablets

KASIER FOUNDATION HOSPITALS

PRINCIPAL DISPLAY PANEL - 25 mcg Tablet Box of 30 Unit Dose Label